Business
CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders
CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders.
About this update from Cardiac Biotech Solutions Inc.
[{"type":"text","content":"Agenda to include matters necessary to better position the company for anticipated growth and developmentESCONDIDO, CA / ACCESSWIRE / November 30, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") has announced it will convene a Special Stockholder Meeting in order to gain approval to implement a number of significant enhancements which management believes will better position CBSC to attain its stated business objectives. As previously disclosed, the Company is actively expanding its market awareness throughout Southeast Asia, especially including China, Malaysia, Thailand, Indonesia, and Singapore."Based on recent progress, our leadership team concluded that the demonstrable progress achieved in key Asian markets, coupled with our recent application to up list to the OTCQB® Venture Market, has created sufficient traction for us to take action to better align the Company for the future success," said Paul Danner, Chairman of CBSC. "Specifically, we plan to seek shareholder approval to implement a corporate name change which more accurately describes our business direction and future growth potential, relocate our corporate domicile to a state which provides superior tax laws and corporate regulations, increase the number of our authorized common shares to facilitate essential fundraising aspirations, ratify the Company's 2021 Omnibus Stock Incentive Plan which we require to recruit and retain the best possible industry talent, as well as certain other actions necessary to properly position us for a potential listing on the Nasdaq exchange at some point in the future."The specific date and time of the Special Stockholder Meeting should be announced within a matter of weeks and will provide requisite notice pursuant to applicable laws, as well as the Company's current Bylaws and Certificate of Incorporation.As additional new developments occur, CB Scientific, Inc. plans to make timely announcements through press releases and regulatory filings to keep its shareholders, industry participants, and the public markets informed.About CB Scientific, Inc.CB Scientific, Inc., through its domestic and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cl...